Clinical trials
Not yet recruiting Overweight trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
254 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2023 | 1 |
| 2024 | 8 |
| 2025 | 39 |
| 2026 | 192 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 254 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novo Nordisk A/S | 5 |
| Pfizer | 5 |
| Eli Lilly and Company | 4 |
| University Hospital, Clermont-Ferrand | 4 |
| Amgen | 3 |
| Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | 3 |
| Huazhong University of Science and Technology | 3 |
| MindRank AI Ltd | 3 |
| National University of Singapore | 3 |
| Ondokuz Mayıs University | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Overweight | 254 |
| Obesity | 237 |
| Weight Loss | 26 |
| Diabetes Mellitus, Type 2 | 22 |
| Prediabetic State | 11 |
| Hypertension | 10 |
| Body Weight | 8 |
| Diabetes Mellitus | 7 |
| Metabolic Syndrome | 7 |
| Dyslipidemias | 6 |
Trials
Showing 51 to 75 of 254. Each trial links to its page on Pharma Observatory.
154 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.